Coral Laboratories Limited (BOM:524506)

Market Cap	2.11B
Revenue (ttm)	1.15B
Net Income (ttm)	241.56M
Shares Out	3.57M
EPS (ttm)	67.61
PE Ratio	8.74
Forward PE	n/a
Dividend	1.50 (0.25%)
Ex-Dividend Date	n/a

Volume	951
Average Volume	2,162
Open	608.00
Previous Close	607.35
Day's Range	594.00 - 614.95
52-Week Range	488.00 - 999.00
Beta	0.81
RSI	32.35
Earnings Date	May 23, 2025

About Coral Laboratories

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant products, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic products, antimalarial drugs, antipsychotic drugs, thyroid, and kits, oral antise...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 142
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524506

Financial Performance

In 2024, Coral Laboratories's revenue was 1.15 billion, an increase of 37.47% compared to the previous year's 836.60 million. Earnings were 241.56 million, an increase of 52.99%.